CDC42 and breast carcinoma: MALAT1 can competitively bind to miR-1, which reduces the ability of miR-1 to inhibit Cdc42, ultimately increasing the level of Cdc42 and inducing cell migration and invasion to promote breast cancer metastasis [191].